Insider tradingForm 4
Veraxa Biotech AG - Post de-SPAC (VRXA) Insider Trading
4 open-market trades reported since Aug 31, 2026: 4 purchases worth $125K and 0 sales worth $0.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Christoph Samuel Ziegler | Director | 1 | $33K | 0 | $0 |
| Warren Hosseinion | Director | 1 | $10K | 0 | $0 |
| Oliver Rolf Baumann | Director | 1 | $75K | 0 | $0 |
| Christoph Rudiger Antz | CEO | 1 | $8K | 0 | $0 |
ADVERTISEMENT
320 × 100 ad slot
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 21 | Christoph Samuel ZieglerDirector | ▲ BUY | $33K | |
| Sep 29 | Warren HosseinionDirector | ▲ BUY | $10K | |
| Aug 31 | Oliver Rolf BaumannDirector | ▲ BUY | $75K | |
| Aug 31 | Christoph Rudiger AntzCEO | ▲ BUY | $8K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings